%0 Journal Article
%T The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C)
%A Akira Tsuburaya
%A Chu Matsuda
%A Hideyuki Mishima
%A Junichi Sakamoto
%A Kazuaki Tanabe
%A Kazuhiro Nishikawa
%A Mari S Oba
%A Masato Kataoka
%A Mitsuru Oshiro
%A Motohiro Imano
%A Naoki Nagata
%A Nobuhiro Takiguchi
%A Ryoji Fukushima
%A Satoshi Morita
%A Takaki Yoshikawa
%A Toru Aoyama
%A Toru Kono
%A Yoshinori Munemoto
%J Journal of Cancer
%D 2018
%I Ivyspring International Publisher
%R 10.7150/jca.24733
%X Background: The current pooled analysis evaluated the efficacy of Hangeshashinto (TJ-14) in the prevention and/or treatment of chemotherapy-induced oral mucositis (COM) in gastric cancer and colorectal cancer using two prospective, multi-institutional, randomized, double-blind, placebo-controlled phase II trials.
%U http://www.jcancer.org/v09p1725.htm